COMMUNIQUÉS West-GlobeNewswire

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
26/03/2018
REGULATED INFORMATION GHENT, Belgium, 26 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]
ABLYNX ANNOUNCES TOPLINE RESULTS FROM THE PHASE II STUDY OF VOBARILIZUMAB IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
26/03/2018
REGULATED INFORMATION - INSIDE INFORMATION GHENT, Belgium, 26 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that the Phase II dose-ranging study of vobarilizumab, the Company's anti-IL-6R [...]
argenx announces orphan drug designation for ARGX-113 for the treatment of myasthenia gravis in Europe
26/03/2018
March 26, 2018 Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the [...]
Targovax ASA: Proposal from the nomination committee to the annual general meeting 11 April 2018
24/03/2018
Reference is made to the notice published on 15 March 2018 regarding the annual general meeting in Targovax ASA (the "Company") to be held on 11 April 2018 at 10:00 am (CEST). The proposal by the Nomination Committee [...]
UPDATED – Hawaii Cannabis Science Dinner & Dialogue Panel to Discuss Company’s Research on the Endocannabinoid System for Breakthrough Therapies
24/03/2018
LOS ANGELES, March 23, 2018 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (“CURE” or the “Company”) (OTC:CURR), an innovative drug delivery and development company, today announced that the Company will participate in an [...]
High Tech Algae Farming Industry Gets Boost with Introduction of Bipartisan Algae Agriculture Act of 2018
23/03/2018
WASHINGTON, March 23, 2018 (GLOBE NEWSWIRE) -- The Algae Biomass Organization (ABO), the trade association for the algae industry, today applauded the introduction of the Algae Agriculture Act of 2018, a bill that would [...]
Healthcare Special Opportunities Fund Announces March 2018 Quarterly Distribution
23/03/2018
NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES TORONTO, March 23, 2018 (GLOBE NEWSWIRE) -- (TSX:MDS.UN) – LDIC Inc. (the “ Manager ”), the manager of Healthcare Special [...]
Publication of the annual report and invitation to the annual shareholders' meeting
23/03/2018
Mechelen, Belgium; 23 March 2018, 21.30 CET; regulated information - Galapagos NV (Euronext & NASDAQ: GLPG) published its annual report for the financial year 2017. The annual report for the financial year 2017, [...]
DBV Technologies Announces Closing of Global Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
23/03/2018
Montrouge, France, March 23, 2018 DBV Technologies Announces Closing of Global Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares DBV Technologies (the "Company") (Euronext: DBV - ISIN: [...]
DBV Technologies annonce la réalisation de son offre globale et l'exercice de la totalité de l'option de surallocation
23/03/2018
Montrouge, France, 23 Mars 2018, 21h00 CET DBV Technologies annonce la réalisation de son offre globale et l'exercice de la totalité de l'option de surallocation DBV Technologies (la « Société ») (Euronext : DBV - ISIN [...]
IntelGenx to Report Fourth Quarter and Full-Year 2017 Financial Results on March 29, 2018 – Conference Call to Follow
23/03/2018
SAINT LAURENT, Quebec, March 23, 2018 (GLOBE NEWSWIRE) -- IntelGenx Technologies Corp. (TSX VENTURE:IGX) (OTCQX:IGXT) today announced that it will release its fourth quarter and full year 2017 financial results after [...]
Corizon Health Names New CMO
23/03/2018
BRENTWOOD, Tenn., March 23, 2018 (GLOBE NEWSWIRE) -- James E. “Pete” Powell, MD, MMHC, has been named Chief Medical Officer of Corizon Health. Corizon Chief Executive Officer Steve Rector announced the addition to his [...]
K2M Group Holdings, Inc. to Participate in the 17th Annual Needham Healthcare Conference
23/03/2018
LEESBURG, Va., March 23, 2018 (GLOBE NEWSWIRE) -- K2M Group Holdings, Inc. (NASDAQ: KTWO ) (the "Company" or "K2M"), a global leader of complex spine and minimally invasive solutions focused on achieving three- [...]
Heart Institute Inaugurates State-of-The-Art Building Expansion
23/03/2018
OTTAWA, March 23, 2018 (GLOBE NEWSWIRE) -- At an Official Inauguration Ceremony held today at the University of Ottawa Heart Institute, Dr. Thierry Mesana, President and CEO, joined Yasir Naqvi, Ontario’s Attorney [...]
L’Institut de cardiologie inaugure ses nouvelles installations de pointe
23/03/2018
OTTAWA, 23 mars 2018 (GLOBE NEWSWIRE) -- Aujourd’hui, dans le cadre de la cérémonie d’inauguration officielle du nouvel édifice de l’Institut de cardiologie de l’Université d’Ottawa, le Dr Thierry Mesana, président- [...]
eFFECTOR Announces Appointment of John W. Smither to its Board of Directors
23/03/2018
SAN DIEGO, March 23, 2018 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced the appointment of John W. [...]
RuddCo Inc. Announces Cannabis Operations Expansion into Jamaica
23/03/2018
MIAMI, March 23, 2018 (GLOBE NEWSWIRE) -- RuddCo Inc., a Florida based company, is announcing an expansion of agricultural operations and the opening of tourist attractions on the island of Jamaica. RuddCo Inc. intends [...]
TiGenix and Takeda announce Alofisel® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn's disease in Europe
23/03/2018
PRESS RELEASE REGULATED INFORMATION INSIDE INFORMATION TiGenix and Takeda announce Alofisel ® (darvadstrocel) receives approval to treat complex perianal fistulas in Crohn's disease in Europe First allogeneic stem cell [...]
TiGenix et Takeda annoncent l'autorisation d'Alofisel® (darvadstrocel) pour le traitement des fistules périanales complexes dans la maladie de Crohn en Europe
23/03/2018
COMMUNIQUÉ DE PRESSE INFORMATIONS RÈGLEMENTÉES INFORMATIONS PRIVILÉGIÉES TiGenix et Takeda annoncent l'autorisation d'Alofisel ® (darvadstrocel) pour le traitement des fistules périanales complexes dans la maladie de [...]

Pages